Additionally, based on the analysis of tumor epithelial cell regions, HLA-DRB5 and RASFRF1 are identified as promising molecular markers for indicating the occurrence of STAS and predicting patient prognosis. The gene discussed is HLA-DRB5; the disease is neoplasm.